Cargando…
Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumor
• Over 90% of granulosa cell tumors have a FOXL2 mutation that contributes to aromatase upregulation. • Chemotherapy has demonstrated limited efficacy in the treatment of granulosa cell tumors. • A patient with recurrent granulosa cell tumor responded briefly to anastrazole treatment. • Retreatment...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750011/ https://www.ncbi.nlm.nih.gov/pubmed/26937482 http://dx.doi.org/10.1016/j.gore.2015.12.004 |